Designer estrogens.
Jordan
V C
VC
D001943:Breast Neoplasms / Q000517:prevention & control*; D003327:Coronary Disease / Q000517:prevention & control*; D016889:Endometrial Neoplasms / Q000517:prevention & control*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D004967:Estrogens / Q000494:pharmacology / Q000502:physiology; D005260:Female; D006801:Humans; D015394:Molecular Structure; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D010880:Piperidines / Q000627:therapeutic use; D017698:Postmenopause; D020849:Raloxifene Hydrochloride; D011960:Receptors, Estrogen / Q000187:drug effects* / Q000502:physiology; D013329:Structure-Activity Relationship; D013629:Tamoxifen / Q000627:therapeutic use
D004965:Estrogen Antagonists; D004967:Estrogens; D010880:Piperidines; D011960:Receptors, Estrogen; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride